Dashboard

Financial News

RSC, Real Estate Caucus Members Urge Treasury to Index Capital Gains to Inflation After Biden-Era Inflation Hit Homeowners
breitbart34d ago

RSC, Real Estate Caucus Members Urge Treasury to Index Capital Gains to Inflation After Biden-Era Inflation Hit Homeowners

Republican Study Committee (RSC) and Congressional Real Estate Caucus members, led by Rep. Mark Alford (R-MO), are transmitting a letter Friday morning to Treasury Secretary Scott Bessent, urging the department to use existing authority to index capital gains calculations to inflation, arguing the change could be implemented administratively without requiring new legislation.The post RSC, Real Estate Caucus Members Urge Treasury to Index Capital Gains to Inflation After Biden-Era Inflation Hit Homeowners appeared first on Breitbart.

#ECONOMY#STOCKS
White Falcon Capital Management’s Investment Thesis for Huntsman Corp (HUN)
insidermonkey34d ago

White Falcon Capital Management’s Investment Thesis for Huntsman Corp (HUN)

White Falcon Capital Management, an investment fund manager, released its fourth-quarter 2025 investor letter. A copy of the letter can be downloaded here. The White Falcon portfolio returned 5.6% (net of fees) in Q4 2025, resulting in a yearly return of 28.4%. The year has been notable, particularly with the “tariff tantrum” in April 2025 that [...]

#STOCKS
globenewswire_fr34d ago

Signing Day Sports Special Stockholder Meeting to Consider and Vote on Proposed Business Combination with BlockchAIn Digital Infrastructure to Be Held March 13, 2026

BlockchAIn Digital Infrastructure Expected to Trade on NYSE American Under Ticker Symbol “AIB” Following Completion of Proposed Business Combination BlockchAIn Digital Infrastructure Expected to Trade on NYSE American Under Ticker Symbol “AIB” Following Completion of Proposed Business Combination

#CRYPTO#STOCKS
benzinga34d ago

Artelo Biosciences Announces Reverse Stock Split

SOLANA BEACH, Calif., March 06, 2026 (GLOBE NEWSWIRE) -- Artelo Biosciences, Inc. (NASDAQ:ARTL) ("Artelo" or the "Company"), a clinical-stage pharmaceutical company focused on modulating lipid-signaling pathways to develop treatments for people living with cancer, pain, dermatological, or neurological conditions, today announced that on February 27, 2026, Artelo's Board of Directors approved a 3-for-1 reverse stock split ("Reverse Split") of the Company's common stock ("Common Stock"). The Company's common shares will begin trading on a split-adjusted basis on the Nasdaq Capital Market commencing at the market open, March 10, 2026. The Board of Directors determined the 3-for-1 ratio to be appropriate in order to increase the price per share of the Common Stock to improve its marketability and liquidity. The new CUSIP number for the Common Stock following the Reverse Split will be 04301G706.As a result of the Reverse Split, each three shares of the Company's issued and outstanding Common Stock will be automatically combined and converted into one issued and outstanding share of Common Stock. No fractional shares will be issued as a result of the Reverse Split. Stockholders who otherwise would be entitled to a fractional share because they hold a number of shares not evenly divisible by ...Full story available on Benzinga.com

#STOCKS
benzinga34d ago

Pacira BioSciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

BRISBANE, Calif., March 06, 2026 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc. (NASDAQ:PCRX), the industry leader in the delivery of innovative, non-opioid pain therapies to transform the lives of patients, today announced the granting of inducement awards on March 3, 2026 to three new employees under Pacira's Amended and Restated 2014 Inducement Plan (the "Inducement Plan") as a material inducement to each employee's entry into employment with the company. In accordance with Nasdaq Listing Rule 5635(c)(4), the awards were approved by the People & Compensation Committee of the Board of Directors (the "Committee") without stockholder approval.One employee received stock options to purchase an aggregate of 2,400 shares of Pacira common stock and three employees received restricted stock units for an aggregate of 5,500 shares of Pacira common ...Full story available on Benzinga.com

#STOCKS
globenewswire34d ago

Prenetics Authorizes $40 Million Share Repurchase Program

NEW YORK, March 06, 2026 (GLOBE NEWSWIRE) -- Prenetics Global Limited (NASDAQ: PRE) ("Prenetics" or the "Company"), a leading consumer health sciences company and parent of the IM8 premium health and longevity brand, today announced that its Board of Directors (the “Board”) has authorized a share repurchase program of up to $40,000,000 over a 12-month period.

#STOCKS